India's Cipla to make and sell Eli Lilly's baricitinib to treat Covid-19

India's Cipla to make and sell Eli Lilly's baricitinib to treat Covid-19 The agreement comes at a time when India is struggling with a catastrophic second wave of the pandemic, leading to an acute shortage of coronavirus medicines such as remdesivir and tocilizumab. https://ift.tt/eA8V8J